Effect of low-density lipoprotein apheresis on circulating endothelial progenitor cells in familial hypercholesterolemia

Blood Purification

Volumn 29, Issue 4, 2010, Pages 383-389

  Ramunni, Alfonso ^a   Brescia, Paola ^a   Dambra, Porzia ^b   Capuzzimati, Laura ^b   Ria, Roberto ^b   De Tullio, Giacoma ^b   Resta, Francesco ^c   Russi, Gianpaolo ^d   Vacca, Angelo ^b   Coratelli, Pasquale ^a  

^a Section of Nephrology   (United States)

^b Section of Internal Medicine   (United States)

^c UNIVERSITY OF BARI   (Italy)

^d S MARIA NUOVA HOSPITAL   (Italy)

Author keywords

Apheresis; Endothelial progenitor cells; Familial hypercholesterolemia; LDL; Low density lipoprotein

Indexed keywords

ATORVASTATIN; CD133 ANTIGEN; CD34 ANTIGEN; CHOLESTEROL; FIBRINOGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN; ROSUVASTATIN; SIMVASTATIN; TRIACYLGLYCEROL; VASCULOTROPIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; APHERESIS; ARTERIAL PRESSURE; ARTICLE; BLOOD SAMPLING; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; FIBRINOGEN BLOOD LEVEL; FLOW CYTOMETRY; HEART RATE; HEMATOCRIT; HUMAN; MALE; PRIORITY JOURNAL; STEM CELL; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL; BLOOD; CASE CONTROL STUDY; CELL COUNT; CONTROLLED CLINICAL TRIAL; HYPERLIPOPROTEINEMIA TYPE II; ISOLATION AND PURIFICATION; MIDDLE AGED; PROCEDURES; STEM CELL MOBILIZATION; TIME;

ADULT; BLOOD COMPONENT REMOVAL; CASE-CONTROL STUDIES; CELL COUNT; CHOLESTEROL, LDL; ENDOTHELIAL CELLS; FEMALE; HEMATOPOIETIC STEM CELL MOBILIZATION; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERLIPOPROTEINEMIA TYPE II; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; STEM CELLS; TIME FACTORS;

EID: 77952302754     PISSN: 02535068     EISSN: None     Source Type: Journal    
DOI: 10.1159/000314650     Document Type: Article

References (40)

1. Ross R: Atherosclerosis is an inflammatory disease. Am Heart J 1999; 138:S419-S420. (Pubitemid 29523224)
2. Schwartz SM, Benditt EP: Clustering of replicating cells in aortic endothelium. Proc Natl Acad Sci USA 1976; 73: 651-653.
3. Gehling UM, Ergün S, Schumacher U, Wagener C, et al: In vitro differentiation of endothelial cells from AC133-positive progenitor cells. Blood 2000; 95: 3106-3112. (Pubitemid 30321161)
4. Gunsilius E, Gastl G, Petzer AL: Hematopoietic stem cells. Biomed Pharmacother 2001; 55: 186-194. (Pubitemid 32429564)
5. Roberts N, Jahangiri M, Xu Q: Progenitor cells in vascular disease. J Cell Mol Med 2005; 9: 583-591. (Pubitemid 44159326)
6. Asahara T, Murohara T, Sullivan A, et al: Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997; 275: 964-967. (Pubitemid 27087709)
7. Rafii S, Lyden D: Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med 2003; 9: 702-712. (Pubitemid 36749219)
8. Kalka C, Masuda H, Takahashi T, et al: Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci 2000; 97: 3422-3427. (Pubitemid 30183318)
9. Libby P: Inflammation in atherosclerosis. Nature 2002; 420: 868-874. (Pubitemid 36019640)
10. Hill JM, Zalos G, Halcox JP, et al: Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003; 348: 593-600. (Pubitemid 36204953)
11. Vasa M, Fichtlscherer S, Aicher A, et al: Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 2001; 89:E1-E7.
12. Tepper OM, Galiano RD, Capla JM, et al: Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 2002; 106: 2781-2786.
13. Ross R, Harker R: Hyperlipidemia and atherosclerosis. Science 1976; 193: 1094-1100.
14. Mabuchi H, Koizumi J, Shimizu M, et al: Development of coronary heart disease in familial hypercholesterolemia. Circulation 1989; 79: 225-232. (Pubitemid 19055492)
15. Rader DJ, Cohen J, Hobbs HH: Monogenic hypercholesterolemia: new insights in pathogenesis and treatment. J Clin Invest 2003; 111: 1795-1803. (Pubitemid 38057721)
16. Tatami R, Inoue N, Itoh H, et al: Regression of coronary atherosclerosis by combined LDL-apheresis and lipid-lowering drug therapy in patients with familial hypercholesterolemia: a multicenter study. The LARS Investigators. Atheroslcerosis 1992; 95: 1-13.
17. Thompson GR, Maher VM, Matthews S, et al: Familial hypercholesterolemia Regression Study: a randomized trial of low-density-lipoprotein apheresis. Lancet 1995; 345: 811-816.
18. Kroon AA, Aengevaeren WR, van der Werf T, et al: LDL-Apheresis Atherosclerosis Regression Study (LAARS). Effect of aggressive versus conventional lipid lowering treatment on coronary atherosclerosis. Circulation 1996; 93: 1826-1835.
19. Ramunni A, Ranieri G, Giancipoli G, et al: Is the efficacy of LDL apheresis in ischemic optic neuropathy linked to a reduction in endothelial activation markers? Blood Purif 2006; 24: 405-412. (Pubitemid 44215187)
20. Dimmeler S, Aicher A, Vasa M, et al: HMGCoA reductase (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway. J Clin Invest 2001; 108: 391-397. (Pubitemid 32730785)
21. Bahlmann FH, DeGroot K, Duckert T, et al: Endothelial progenitor cell proliferation and differentiation is regulated by erythropoietin. Kidney Int 2003; 64: 1648-1652. (Pubitemid 37323692)
22. Strehlow K, Werner R, Berweiler J, et al: Estrogen increases bone marrow-derived endothelial progenitor cell production and diminishes neointima formation. Circulation 2003; 107: 3059-3065. (Pubitemid 36758980)
23. Bahlmann FH, deGroot KD, Mueller O, et al: Stimulation of endothelial progenitor cell. A new putative therapeutic effect of angiotensin II receptor antagonists. Hypertension 2005; 45: 526-529. (Pubitemid 40411254)
24. Laufs U, Werner R, Link A, et al: Physical training increases endothelial progenitor cells, inhibits neointima formation, and enhances angiogenesis. Circulation 2004; 109: 220-226. (Pubitemid 38114143)
25. Susca M: Heparin-induced extracorporeal low density lipoprotein precipitation Futura, a new modification of HELP apheresis: technique and first clinical results. Ther Apher 2001; 5: 387-393. (Pubitemid 34033337)
26. Gill M, Dias S, Hattori K, et al: Vascular trauma induces transient but rapid mobilization of VEGFR2(+)AC133(+) endothelial progenitor cells. Circ Res 1999; 85: 221-228.
27. Peichev M, Naiyer AJ, Pereira D, et al: Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 2000; 95: 952-958. (Pubitemid 30062717)
28. Sturiale A, Coppolino G, Loddo S, et al: Effects of haemodialysis on circulating endothelial progenitor cell count. Blood Purif 2007; 25: 242-251. (Pubitemid 47074637)
29. Rabbany SY, Heissig B, Hattori K, Rafii S: Molecula pathways regulating mobilization of marrow-derived stem cells for tissue revascularization. Trends Mol Med 2003; 9: 109-117. (Pubitemid 36433892)
30. Hattori K, Dias S, Heissig B, et al: Vascular endothelial growth factor and angiopoietin-1 stimulate postnatal hematopoiesis by recruitment of vasculogenic and hematopoietic stem cells. J Exp Med 2001; 193: 1005-1014. (Pubitemid 32436194)
31. Rauscher FM, Goldschmidt-Clermont PJ, Davis BH, et al: Aging, progenitor cell exhaustion, and atherosclerosis. Circulation 2003; 108: 457-463. (Pubitemid 36935540)
32. Schmidt-Lucke C, Rössig L, Fichtlscherer S, et al: Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events. Proof of concept for the clinical importance of endogenous vascular repair. Circulation 2005; 111: 2981-2987. (Pubitemid 40814192)
33. Werner N, Kosiol S, Schiegl T, et al: Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 2005; 353: 999-1007. (Pubitemid 41262334)
34. Vasa M, Fichtscherer S, Adler K, et al: Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation 2001; 103: 2885-2890. (Pubitemid 32578123)
35. Hristov M, Fach C, Becker C, et al: Reduced number of circulating endothelial progenitor cells in patients with coronary artery disease associated with long-term statin treatment. Atherosclerosis 2007; 192: 413-420. (Pubitemid 46726323)
36. Schmaldienst S, Banyai S, Stulnig TM, et al: Prospective randomised cross-over comparison of three LDL-apheresis systems in statin pretreated patients with familial hypercholesterolaemia. Atherosclerosis 2000; 151: 493-499. (Pubitemid 30618766)
37. Gordon DJ, Probstfield JL, Garrison RJ, et al: High density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation 1989; 79: 8-15.
38. Toth PP: High density lipoprotein as a therapeutic target: clinical evidence and treatment strategies. Am J Cardiol 2005; 96: 50K-58K; discussion 34K-35K. (Pubitemid 41598113)
39. Navab M, Ananthramaiah GM, Reddy ST, et al: The double jeopardy of HDL. Ann Med 2005; 37: 173-178. (Pubitemid 40780434)
40. Opole IO, Belmont JM, Kumar A, Moriarty PM: Am J Cardiol 2007; 100: 1416-1418.